Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shiyi Yu

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
International Journal of Biological Sciences|May 23, 2017
Targeting HSP90-HDAC6 Regulating Network Implicates Precision Treatment of Breast CancerShiyi Yu, Xiuxiu Cai, Chenxi Wu, et al.
Cell Death & Disease|March 6, 2021
Ciclopirox and bortezomib synergistically inhibits glioblastoma multiforme growth via simultaneously enhancing JNK/p38 MAPK and NF-κB signalingZhipeng Su, Shengnan Han, Qiumei Jin, et al.
Oncogene|August 20, 2024
Alternative splicing of ALDOA confers tamoxifen resistance in breast cancerShiyi Yu, Rui Wu, Yue Si, et al.
Nature Communications|December 12, 2025
Plasma proteomic profiles identify biomarkers predicting Crohn's disease up to 16 years before onsetJing Feng, Shuo Chen, Qinming Li, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
International Journal of Biological Sciences|May 23, 2017
Targeting HSP90-HDAC6 Regulating Network Implicates Precision Treatment of Breast CancerShiyi Yu, Xiuxiu Cai, Chenxi Wu, et al.
Cell Death & Disease|March 6, 2021
Ciclopirox and bortezomib synergistically inhibits glioblastoma multiforme growth via simultaneously enhancing JNK/p38 MAPK and NF-κB signalingZhipeng Su, Shengnan Han, Qiumei Jin, et al.
Oncogene|August 20, 2024
Alternative splicing of ALDOA confers tamoxifen resistance in breast cancerShiyi Yu, Rui Wu, Yue Si, et al.
Nature Communications|December 12, 2025
Plasma proteomic profiles identify biomarkers predicting Crohn's disease up to 16 years before onsetJing Feng, Shuo Chen, Qinming Li, et al.
Pageof 4